See also this year's filing and all EDGAR filings for this company.
PDF Report 0001106644_2013_China_Pharma_Holdings_INC.pdf
Logs
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'OperatingIncomeLoss'} |
Graph
Absolute values for 0001106644, China Pharma Holdings INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 112,531,188 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,412,854 |
| 2 | PropertyPlantAndEquipmentNet | 9,031,894 |
| 3 | remainder_Assets | 39,263,977 |
| 4 | LiabilitiesCurrent | 14,627,383 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 95,963 |
| 7 | CostOfGoodsAndServicesSold | 38,660,814 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,313,306 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 6,769,905 |
| 11 | remainder_Revenues | 54,649,036 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -13,261 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 163,239,913 |
| 1 | Liabilities | 14,723,346 |
| 2 | Expenses | 48,744,025 |
| 3 | Revenues | 54,649,036 |
| 4 | StockholdersEquity | 148,516,567 |
| 5 | NetIncome | 5,905,011 |
| 6 | ComprehensiveNetIncome | 5,898,380 |
| 7 | BaseVar | 140,684,790 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.70 |
| 9 | EconomicCapitalRatio | 4.18 |
Edgar->Model Mapping
Feature Distribution
